Cargando…

CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway

INTRODUCTION: The mechanism of tumorigenesis and metastasis of ovarian cancer has not yet been elucidated. This study aimed to investigate the role and molecular mechanism of cytosolic nonspecific dipeptidase 2 in tumorigenesis and metastasis. METHODS: Cytosolic nonspecific dipeptidase 2 expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li Q., Yang, Hua Q., Yang, Su Q., Wang, Ying, Chen, Xian J., Lu, Hong S., Zhao, Ling P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755628/
https://www.ncbi.nlm.nih.gov/pubmed/31537175
http://dx.doi.org/10.1177/1533033819874773
_version_ 1783453274194575360
author Zhang, Li Q.
Yang, Hua Q.
Yang, Su Q.
Wang, Ying
Chen, Xian J.
Lu, Hong S.
Zhao, Ling P.
author_facet Zhang, Li Q.
Yang, Hua Q.
Yang, Su Q.
Wang, Ying
Chen, Xian J.
Lu, Hong S.
Zhao, Ling P.
author_sort Zhang, Li Q.
collection PubMed
description INTRODUCTION: The mechanism of tumorigenesis and metastasis of ovarian cancer has not yet been elucidated. This study aimed to investigate the role and molecular mechanism of cytosolic nonspecific dipeptidase 2 in tumorigenesis and metastasis. METHODS: Cytosolic nonspecific dipeptidase 2 expression in human ovarian cancer tissues and cell lines was assessed with methyl thiazolyl tetrazolium (MTT), clone formation, and transwell assays performed to evaluate the ability of ovarian cancer cells to proliferate and migrate. Nude mice tumor formation experiments were also performed by subcutaneously injecting cells with stable cytosolic nonspecific dipeptidase 2 knockdown and control SKOV3 cells into BALB/c female nude mice to detect changes in PI3K/AKT pathway-related proteins by Western blotting. RESULTS: Cytosolic nonspecific dipeptidase 2 was highly expressed in human ovarian cancer tissues, with its expression associated with pathological data, including ovarian cancer metastasis. A cytosolic nonspecific dipeptidase 2 stable knockdown or ectopic expression ovarian cancer cell model was established and demonstrated that cytosolic nonspecific dipeptidase 2 could promote the proliferation of ovarian cancer cells. Transwell cell migration and invasion assays confirmed that cytosolic nonspecific dipeptidase 2 enhanced cell metastasis in ovarian cancer. Furthermore, in vivo xenograft experiments demonstrated that cytosolic nonspecific dipeptidase 2 can promote the development and progression of ovarian cancer, increasing the expression of phosphorylated PI3K and AKT. CONCLUSIONS: Cytosolic nonspecific dipeptidase 2 promotes the occurrence and development of ovarian cancer through the PI3K/AKT signaling pathway.
format Online
Article
Text
id pubmed-6755628
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-67556282019-09-27 CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway Zhang, Li Q. Yang, Hua Q. Yang, Su Q. Wang, Ying Chen, Xian J. Lu, Hong S. Zhao, Ling P. Technol Cancer Res Treat Original Article INTRODUCTION: The mechanism of tumorigenesis and metastasis of ovarian cancer has not yet been elucidated. This study aimed to investigate the role and molecular mechanism of cytosolic nonspecific dipeptidase 2 in tumorigenesis and metastasis. METHODS: Cytosolic nonspecific dipeptidase 2 expression in human ovarian cancer tissues and cell lines was assessed with methyl thiazolyl tetrazolium (MTT), clone formation, and transwell assays performed to evaluate the ability of ovarian cancer cells to proliferate and migrate. Nude mice tumor formation experiments were also performed by subcutaneously injecting cells with stable cytosolic nonspecific dipeptidase 2 knockdown and control SKOV3 cells into BALB/c female nude mice to detect changes in PI3K/AKT pathway-related proteins by Western blotting. RESULTS: Cytosolic nonspecific dipeptidase 2 was highly expressed in human ovarian cancer tissues, with its expression associated with pathological data, including ovarian cancer metastasis. A cytosolic nonspecific dipeptidase 2 stable knockdown or ectopic expression ovarian cancer cell model was established and demonstrated that cytosolic nonspecific dipeptidase 2 could promote the proliferation of ovarian cancer cells. Transwell cell migration and invasion assays confirmed that cytosolic nonspecific dipeptidase 2 enhanced cell metastasis in ovarian cancer. Furthermore, in vivo xenograft experiments demonstrated that cytosolic nonspecific dipeptidase 2 can promote the development and progression of ovarian cancer, increasing the expression of phosphorylated PI3K and AKT. CONCLUSIONS: Cytosolic nonspecific dipeptidase 2 promotes the occurrence and development of ovarian cancer through the PI3K/AKT signaling pathway. SAGE Publications 2019-09-19 /pmc/articles/PMC6755628/ /pubmed/31537175 http://dx.doi.org/10.1177/1533033819874773 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Zhang, Li Q.
Yang, Hua Q.
Yang, Su Q.
Wang, Ying
Chen, Xian J.
Lu, Hong S.
Zhao, Ling P.
CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
title CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
title_full CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
title_fullStr CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
title_full_unstemmed CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
title_short CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
title_sort cndp2 acts as an activator for human ovarian cancer growth and metastasis via the pi3k/akt pathway
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755628/
https://www.ncbi.nlm.nih.gov/pubmed/31537175
http://dx.doi.org/10.1177/1533033819874773
work_keys_str_mv AT zhangliq cndp2actsasanactivatorforhumanovariancancergrowthandmetastasisviathepi3kaktpathway
AT yanghuaq cndp2actsasanactivatorforhumanovariancancergrowthandmetastasisviathepi3kaktpathway
AT yangsuq cndp2actsasanactivatorforhumanovariancancergrowthandmetastasisviathepi3kaktpathway
AT wangying cndp2actsasanactivatorforhumanovariancancergrowthandmetastasisviathepi3kaktpathway
AT chenxianj cndp2actsasanactivatorforhumanovariancancergrowthandmetastasisviathepi3kaktpathway
AT luhongs cndp2actsasanactivatorforhumanovariancancergrowthandmetastasisviathepi3kaktpathway
AT zhaolingp cndp2actsasanactivatorforhumanovariancancergrowthandmetastasisviathepi3kaktpathway